Type 2 Asthma Learning Hub

Welcome to Type 2 Asthma learning hub gathering key medical educational ADVENT resources on the role of type 2 in asthma.

Type 2 asthma is a common phenotype of asthma, characterized by key cytokines IL-4, IL-13, and IL-5, as well as elevated type 2 inflammatory biomarkers as FeNO, and eosinophils, or the need for maintenance OCS. Type 2 inflammation is evident in up to 88% of patients with severe asthma, representing a substantial portion of the disease burden associated with asthma. Explore the resources below better understand the role of type 2 inflammation in asthma.

Type 2 asthma is a common phenotype of asthma, characterized by key cytokines IL-4, IL-13, and IL-5, as well as elevated type 2 inflammatory biomarkers as FeNO, and eosinophils, or the need for maintenance OCS. Type 2 inflammation is evident in up to 88% of patients with severe asthma, representing a substantial portion of the disease burden associated with asthma. Explore the resources below better understand the role of type 2 inflammation in asthma.

Biomarkers for Type 2 Asthma

Explore in greater detail which are the key mediators in Type 2 asthma.

Asthma Events of Interest

Asthma Events of Interest highlight congresses and latest educational opportunities relating to understanding the science of Asthma.

Related events

Test your knowledge

Check your understanding of the latest clinical insights and disease management.
MAT-GLB-2504167 - 1.0 - 10/2025